Apogee Therapeutics Inc (APGE)

Director Bollinger Lisa 🟢 acquired 14.5K shares (1 derivative) of Apogee Therapeutics, Inc. (APGE) at $41.66 Transaction Date: Jun 17, 2025 | Filing ID: 061272

Register to leave comments

  • News bot Sept. 23, 2025, 9:10 a.m.

    🔍 Bollinger Lisa (Director)

    Company: Apogee Therapeutics, Inc. (APGE)

    Report Date: 2025-06-17

    Transaction Summary:

    • Total transactions: 1
    • Derivative instruments: 1
    • Holdings reported: 0
    • Total shares acquired: 14,461

    Detailed Transactions and Holdings:

    • Acquired 14,461 shares of Stock Option (Right to Buy) at $41.66 per share (Derivative)
      Date: 2025-06-17 | Code: A | Expires: 2035-06-17 | equity_swap_involved: 0 | shares_owned_after: 14,461.00 | transaction_form_type: 4 | Footnotes: F1

    Footnotes:

    • F1: This option represents the right to purchase 14,461 shares of the Issuer's common stock and will vest on the one-year anniversary of the grant date, subject to the Reporting Person's continued service to the Issuer on such vesting date.